COMPARATIVE STUDY OF CLOBAZAM USED AS AN ADD ON THERAPY WITH PHENYTION AND CARBAMAZEPINE IN REFRACTORY EPILEPSY.
DOI:
https://doi.org/10.32553/ijmbs.v2i6.113Abstract
Refractory epilepsy is a failure of two (2) appropriately used anti epileptics (AED). This study Is a comparative study of clobzam use as add on with phenytoin and carbarnazepine.
Aims & Objectives: Aim of this study is to know how much Clobazam is effective as add on therapy in refractory epilepsy.
Material and Methods: In this study two refractory groups of epilepsy are selected. group - 1 is refractory with phenytoin and Group-II with Carbamazepine. Clobazam(10mg) was added to both refractory groups and follow up For 3 Years.
Results: There is significant reduction in seizure frequency after addition of clobazam in both refractory groups and 25% Patients were becomes completely seizure free.
Discussion: This study was conducted in ANMMCH, Gaya Patients were selected from both outdoor & Indoor of Medicine department and found 77.16% reduction in seizure frequency in group —I i;e with phenytoin and clobazam 78.16% in Group-II z;e with carbamazepine and clobazam and 25% Patients becomes completely seizure free.
Conclusion: Clobazam is a very effective and safe AED for add on Therapy.
Keywords: Refractory epilepsy Add on therapy mean seizure frequency
